PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.113930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Ying Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Basic Medical Sciences, Beijing 100850, China. Hauptthemen laut MEDLINE: Oligodendrocyte Precursor Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Sichuan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Oligodendrocyte progenitor cells (OPCs) differentiate into myelin-producing cells and modulate neuronal activity. Defects in OPC development are associated with neurological diseases. N6-methyladenosine (m6A) contributes to neural development; however, the mechanism by which m6A regulates OPC development remains unclear. Here, we demonstrate that PRRC2B is an m6A reader that regulates OPC development and myelination. Nestin-Cre-mediated Prrc2b deletion affects neural stem cell self-renewal and glial differentiation. Moreover, the oligodendroglia lineage-specific deletion of Prrc2b reduces the numbers of OPCs and oligodendrocytes, causing hypomyelination and impaired motor coordination. Integrative methylated RNA immunoprecipitation sequencing, RNA sequencing, and RNA immunoprecipitation sequencing analyses identify Sox2 as the target of PRRC2B. Notably, PRRC2B, displaying separate and cooperative functions with PRRC2A, stabilizes mRNA by binding to m6A motifs in the coding sequence and 3' UTR of Sox2. In summary, we identify the posttranscriptional regulation of PRRC2B in OPC development, extending the understanding of PRRC2 family proteins and providing a therapeutic target for myelin-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Basic Medical Sciences, Beijing 100850, China.
- Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou 221004, China.
- Beijing Institute of Basic Medical Sciences, Beijing 100850, China; School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China.
- Center on Translational Neuroscience, College of Life and Environmental Science, Minzu University of China, Beijing 100081, China; Key Laboratory of Neurology (Hebei Medical University), Ministry of Education, Shijiazhu…
- Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China.
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- Sichuan University
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Directorate for Biological Sciences
Zitieren
APA
Zhang, Y., Song, Z., Wu, R., Kong, X., Zhang, H., Li, S., Gong, X., Gong, S., Cheng, J., Yuan, F., Wu, H., Wang, S., & Yuan, Z. (2024). PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA. Cell Reports. https://doi.org/10.1016/j.celrep.2024.113930
Vancouver
Zhang Y, Song Z, Wu R, Kong X, Zhang H, Li S, et al. PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA. Cell Reports. 2024. doi:10.1016/j.celrep.2024.113930
BibTeX
@article{Zhang2024,
author = {Zhang, Ying and Song, Zhihong and Wu, Rong and Kong, Xiangxi and Zhang, Hongye and Li, Shuoshuo and Gong, Xuanwei and Gong, Shenghui and Cheng, Jinbo and Yuan, Fang and Wu, Haitao and Wang, Shukun and Yuan, Zengqiang},
title = {PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.113930}
}
EUVIMED